Hepatitis A vaccination coverage in adults with chronic liver disease in primary care in England: a retrospective cohort study
Meza-Torres B. et al, (2025), Lancet Public Health, 10, e647 - e655
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care population
Forbes AK. et al, (2025), Nephrology Dialysis Transplantation, 40, 71 - 82
Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study
Greenwood DC. et al, (2024), The Lancet Regional Health - Europe, 46
Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study
Tsang RSM. et al, (2024), Journal of the Royal Society of Medicine, 117, 134 - 148
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Meeraus W. et al, (2024), Journal of Infection, 88
Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study
Forbes AK. et al, (2024), Eclinicalmedicine, 68
Sodium-glucose cotransporter-2 inhibitors and kidney outcomes in real-world type 2 diabetes populations: A systematic review and meta-analysis of observational studies
Forbes AK. et al, (2023), Diabetes, Obesity and Metabolism, 25, 2310 - 2330
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies
Hinton W. et al, (2023), Diabetes, Obesity and Metabolism, 25, 501 - 515
Hepatitis A Vaccination Coverage Among People With Chronic Liver Disease in England (HEALD): Protocol for a Retrospective Cohort Study
Meza-Torres B. et al, (2023), JMIR Research Protocols, 12
Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people
Dambha-Miller H. et al, (2023), Family Practice, 40, 330 - 337
Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study
Dambha-Miller H. et al, (2022), Family Practice, 39, 1049 - 1055
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study
de Lusignan S. et al, (2022), Diabetes Therapy, 13, 1789 - 1809
BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database
Lemanska A. et al, (2022), PLoS ONE, 17
Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study
Whyte MB. et al, (2022), Diabetes, Obesity and Metabolism, 24, 1310 - 1318
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study)
Feher M. et al, (2022), Jmir Research Protocols, 11
The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study
Mathew M. et al, (2022), JMIR Research Protocols, 11